Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
2 hedge funds and large institutions have $145K invested in Cellectar Biosciences, Inc. Series A Warrants in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
+$126K |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$5.01K |
Top Sellers
CLRBZ Hedge Fund Activity: Q2 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q2 2016, worth a combined $145K.
Buyers outnumbered sellers: 2 funds opened new CLRBZ positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Ionic Capital Management, opening a new position worth an estimated $126K.
- 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $145K of Cellectar Biosciences, Inc. Series A Warrants stock for Q2 2016.
- 2 funds opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q2 2016 and 0 closed out, a net change of +2 holders.
- The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q2 2016 was Ionic Capital Management, an estimated $126K added.
Based on aggregated 13F filings for Q2 2016.